A Cost Model for a Low-Threshold Clinic Treating Opioid Use Disorder

被引:0
|
作者
Wakeman, Sarah E. [1 ]
Powell, Elizabeth [2 ]
Shehab, Syed [3 ]
Herman, Grace [4 ]
Kehoe, Laura [1 ]
Kaplan, Robert S. [3 ,5 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA
[3] Harvard Univ, Cambridge, MA USA
[4] Univ Buffalo, Jacobs Sch Med, Buffalo, NY USA
[5] Harvard Sch Business, Boston, MA 02163 USA
关键词
BUPRENORPHINE; PEOPLE;
D O I
10.1007/s11414-023-09853-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic's ability to expand and improve access, especially for socially marginalized patients with OUD. New payment models, however, should reflect the high variation in cost for using a clinic's clinical and voluntary psychosocial and recovery support services. The authors applied time-driven activity-based costing, a patient-level, micro-costing approach, to estimate the cost at an outpatient clinic that delivers medication for opiate used disorder (MOUD) and voluntary psychosocial and recovery support services. Much of the cost variation could be explained by classifying patients into three archetypes: (1) light touch (1-3 visits): no significant co-occurring psychiatric illness, stable housing, and easy to connect for ongoing OUD treatment in a traditional outpatient setting; (2) standard (average of 8 visits): initially requires an integrated team-based care model but soon stabilizes for transition to community-based outpatient care; (3) quad morbidity (> 20 visits): multiple co-occurring substance use disorders, unhoused, co-occurring medical and psychiatric complexity, and limited social supports. With the cost of the initial visit set at an indexed value of 100, an average light touch patient had a cost of 352, a standard patient was 718, and a quad morbidity patient was 1701. The cost structure revealed by this analysis provides the foundation for alternative payment models that would enable new MOUD clinics, staffed with multi-disciplinary care teams, and located for convenient access by high-risk patients, to be established and sustained.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [31] Janus LAAM-loaded electrospun fibrous buccal films for treating opioid use disorder
    Sudarjat, Hadi
    Qin, Chaolong
    Ingabire, Diane
    Raynold, Aji Alex Moothedathu
    Pangeni, Rudra
    Pearcy, Adam
    Meng, Tuo
    Zhao, Long
    Arriaga, Michelle
    Chow, Woon N.
    Puetzer, Jennifer L.
    Lu, Xiuling
    Moeller, F. Gerard
    Halquist, Matthew S.
    O'Keeffe, Charles
    Banks, Matthew L.
    Xu, Qingguo
    BIOMATERIALS, 2025, 317
  • [32] A Financial Model for Team-Based Opioid Use Disorder Treatment
    Farrar, Mackenzie
    White, Zach
    Hulkower, Stephen
    Fagan, E. Blake
    Wilson, Courtenay Gilmore
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (01) : 124 - 128
  • [33] "I want to stay here": Patient and staff perspectives on transitioning from a low-threshold buprenorphine program to clinic-based care
    Martinez, Noelle G.
    Truong, Ashley Q.
    Nordeck, Courtney D.
    Agus, Deborah
    Genberg, Becky L.
    Buresh, Megan E.
    DRUG AND ALCOHOL DEPENDENCE, 2024, 257
  • [34] A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study
    Shashi N. Kapadia
    Judith L. Griffin
    Justine Waldman
    Nicolas R. Ziebarth
    Bruce R. Schackman
    Czarina N. Behrends
    Journal of General Internal Medicine, 2021, 36 : 1898 - 1905
  • [35] A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study
    Kapadia, Shashi N.
    Griffin, Judith L.
    Waldman, Justine
    Ziebarth, Nicolas R.
    Schackman, Bruce R.
    Behrends, Czarina N.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (07) : 1898 - 1905
  • [36] Implementation of a hospital-based intervention for MOUD initiation and referral to a Bridge Clinic for opioid use disorder
    Audet, Carolyn M.
    Pettapiece-Phillips, Mariah
    Kast, Kristopher
    White, Katie D.
    Perkins, Jessica M.
    Marcovitz, David
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 146
  • [37] Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study
    Kiburi, Sarah Kanana
    Mwangi, Jackline
    Maina, Geoffrey
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)
  • [38] Satisfaction with group-based appointments among patients with opioid use disorder in an urban buprenorphine clinic
    Akyar, Serra
    Nyaku, Amesika
    Lao, Kristyn
    Ruthberg, Stephanie
    Zerbo, Erin A.
    SUBSTANCE ABUSE, 2022, 43 (01) : 913 - 916
  • [39] Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series
    Murray, John P.
    Pucci, Geoffrey
    Weyer, George
    Ari, Mim
    Dickson, Sarah
    Kerins, Angela
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [40] Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
    Haffajee, Rebecca L.
    Lin, Lewei Allison
    Bohnert, Amy S. B.
    Goldstick, Jason E.
    JAMA NETWORK OPEN, 2019, 2 (06) : e196373